
|Articles|March 11, 2022
Choose Eurofins’ new state-of-the-art aseptic sterile fill/finish for clinical supplies
Author(s)Eurofins BioPharma Product Testing
Industry changes, such as shorter timelines and increased product complexity, can often introduce additional risks to the sterile fill/finish process, resulting in production delays, additional costs, and safety concerns.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Syngene Extends Major Research Collaboration with BMS
2
Sharp Expands European Injectable Packaging Capacity With €20 million Investment
3
The Shift from Containment to Protection: Packaging Trends Impacting Pharma
4
State of the Bio/Pharma Workforce: A Comparative Analysis of Employment Trends and Industry Sentiment
5